1. Center for Interstitial Lung Diseases, Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine,
2. Department of Laboratory Medicine and Pathology, and
3. ZS Associates, Global Health Economics and Outcomes Research, New York, New York;
4. Division of Epidemiology and
5. Division of Biostatistics, Department of Population Health, New York University Langone Health, New York, New York;
6. Department of Biostatistics, University of Washington, Seattle, Washington;
7. Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York;
8. Department of Medicine V, LMU University Hospital, Ludwig-Maximilians-University Munich, Member of the German Center for Lung Research, Munich, Germany;
9. Department of Medicine and
10. Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;
11. Division of Cardiothoracic Radiology, Department of Radiology, University of Michigan Health System, Detroit, Michigan;
12. Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California;
13. Divisione di Medicina Polmonare, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy;
14. Department of Medicine, Tulane University, New Orleans, Louisiana;
15. Division of Pulmonology, Allergy, and Critical Care, Office of Immunology and Inflammation, and
16. Division of Biometrics III, Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, and
17. Division of Clinical Outcome Assessment, Office of Drug Evaluation Sciences, Office of New Drugs, and
18. Office of Product Evaluation and Quality, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland;
19. Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland;
20. Division of Pulmonary Medicine, St. Luke’s Hospital, Chesterfield, Missouri;
21. Department of Radiology, University of California, Los Angeles, Los Angeles, California;
22. Department of Medicine, Stritch School of Medicine, Loyola Chicago, Chicago, Illinois;
23. Hcor Research Institute – Hcor Hospital, São Paolo, Brazil;
24. Pulmonary Division, Heart Institute (InCor), University of São Paulo, São Paulo, Brazil;
25. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada;
26. Division of Pulmonary, Critical Care, and Sleep Medicine, Vanderbilt University, Nashville, Tennessee;
27. Department of Radiology, National Jewish Health, Denver, Colorado;
28. Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor University, Dallas, Texas;
29. Division of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, Virginia;
30. Pulmonary Fibrosis Foundation, Chicago, Illinois;
31. Centre of Interstitial Lung Diseases, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands;
32. Patient representative and patient living with IPF, Lovettsville, Virginia;
33. Patient representative and patient living with IPF, Charlottesville, Virginia; and
34. Patient representative and patient living with IPF, Richmond, Virginia